Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
03 juil. 2024 08h05 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
07 sept. 2022 17h00 HE
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...